Medical Devices & Consumables
Radiopharmaceutical Injector- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
- Jul 14, 25
- ID: 374644
- Pages: 92
- Figures: 107
- Views: 7
The global market for Radiopharmaceutical Injector was estimated to be worth US$ 32.2 million in 2024 and is forecast to a readjusted size of US$ 52.5 million by 2031 with a CAGR of 7.4% during the forecast period 2025-2031.
A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.
The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient"s body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient"s body and accurate imaging or therapeutic results.
Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Injector, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Radiopharmaceutical Injector by region & country, by Type, and by Application.
The Radiopharmaceutical Injector market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Injector.
Market Segmentation
By Company
Medrad, Inc.(Bayer)
UNIVERSAL GIKEN
Comecer
Sumitomo Heavy Industries
Tema Sinergie
Lemer Pax
BQSV
Segment by Type
PET Radioactive Drugs Injector
PET and SPECT Radioactive Drugs Injector
Segment by Application
Hospitals and Clinics
R&D Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Radiopharmaceutical Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Radiopharmaceutical Injector in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
A radiopharmaceutical injector is a medical device used to administer radiopharmaceuticals to patients. Radiopharmaceuticals are drugs that contain radioactive isotopes, which emit gamma rays or positrons that can be detected by specialized imaging equipment. These drugs are used in nuclear medicine for diagnostic imaging and therapy.
The radiopharmaceutical injector is specifically designed to safely and accurately deliver these radioactive drugs into the patient"s body. It ensures precise control over the injection process, including the injection rate, volume, and timing. This control is crucial to ensure optimal distribution of the radiopharmaceutical within the patient"s body and accurate imaging or therapeutic results.
Global key players of Radiopharmaceutical Injector include Medrad, Inc.(Bayer), UNIVERSAL GIKEN and Comecer, etc. The top three players hold a share over 65%. Medrad, Inc.(Bayer) is the largest manufacturers of Radiopharmaceutical Injector in the world, has a share about 30%. Europe is the largest market, has a share about 35%. In terms of product type, PET Radioactive Drugs Injector is the largest segment, occupied for a share of 85%, and in terms of application, Hospitals and Clinics has a share about 80 percent.
This report aims to provide a comprehensive presentation of the global market for Radiopharmaceutical Injector, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Radiopharmaceutical Injector by region & country, by Type, and by Application.
The Radiopharmaceutical Injector market size, estimations, and forecasts are provided in terms of sales volume (Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Radiopharmaceutical Injector.
Market Segmentation
By Company
Medrad, Inc.(Bayer)
UNIVERSAL GIKEN
Comecer
Sumitomo Heavy Industries
Tema Sinergie
Lemer Pax
BQSV
Segment by Type
PET Radioactive Drugs Injector
PET and SPECT Radioactive Drugs Injector
Segment by Application
Hospitals and Clinics
R&D Institution
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Radiopharmaceutical Injector manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Radiopharmaceutical Injector in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Radiopharmaceutical Injector in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
1 Market Overview
1.1 Radiopharmaceutical Injector Product Introduction
1.2 Global Radiopharmaceutical Injector Market Size Forecast
1.2.1 Global Radiopharmaceutical Injector Sales Value (2020-2031)
1.2.2 Global Radiopharmaceutical Injector Sales Volume (2020-2031)
1.2.3 Global Radiopharmaceutical Injector Sales Price (2020-2031)
1.3 Radiopharmaceutical Injector Market Trends & Drivers
1.3.1 Radiopharmaceutical Injector Industry Trends
1.3.2 Radiopharmaceutical Injector Market Drivers & Opportunity
1.3.3 Radiopharmaceutical Injector Market Challenges
1.3.4 Radiopharmaceutical Injector Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Radiopharmaceutical Injector Players Revenue Ranking (2024)
2.2 Global Radiopharmaceutical Injector Revenue by Company (2020-2025)
2.3 Global Radiopharmaceutical Injector Players Sales Volume Ranking (2024)
2.4 Global Radiopharmaceutical Injector Sales Volume by Company Players (2020-2025)
2.5 Global Radiopharmaceutical Injector Average Price by Company (2020-2025)
2.6 Key Manufacturers Radiopharmaceutical Injector Manufacturing Base and Headquarters
2.7 Key Manufacturers Radiopharmaceutical Injector Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Radiopharmaceutical Injector
2.9 Radiopharmaceutical Injector Market Competitive Analysis
2.9.1 Radiopharmaceutical Injector Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceutical Injector Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Injector as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PET Radioactive Drugs Injector
3.1.2 PET and SPECT Radioactive Drugs Injector
3.2 Global Radiopharmaceutical Injector Sales Value by Type
3.2.1 Global Radiopharmaceutical Injector Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Radiopharmaceutical Injector Sales Value, by Type (2020-2031)
3.2.3 Global Radiopharmaceutical Injector Sales Value, by Type (%) (2020-2031)
3.3 Global Radiopharmaceutical Injector Sales Volume by Type
3.3.1 Global Radiopharmaceutical Injector Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Radiopharmaceutical Injector Sales Volume, by Type (2020-2031)
3.3.3 Global Radiopharmaceutical Injector Sales Volume, by Type (%) (2020-2031)
3.4 Global Radiopharmaceutical Injector Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 R&D Institution
4.2 Global Radiopharmaceutical Injector Sales Value by Application
4.2.1 Global Radiopharmaceutical Injector Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Radiopharmaceutical Injector Sales Value, by Application (2020-2031)
4.2.3 Global Radiopharmaceutical Injector Sales Value, by Application (%) (2020-2031)
4.3 Global Radiopharmaceutical Injector Sales Volume by Application
4.3.1 Global Radiopharmaceutical Injector Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Radiopharmaceutical Injector Sales Volume, by Application (2020-2031)
4.3.3 Global Radiopharmaceutical Injector Sales Volume, by Application (%) (2020-2031)
4.4 Global Radiopharmaceutical Injector Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Radiopharmaceutical Injector Sales Value by Region
5.1.1 Global Radiopharmaceutical Injector Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Radiopharmaceutical Injector Sales Value by Region (2020-2025)
5.1.3 Global Radiopharmaceutical Injector Sales Value by Region (2026-2031)
5.1.4 Global Radiopharmaceutical Injector Sales Value by Region (%), (2020-2031)
5.2 Global Radiopharmaceutical Injector Sales Volume by Region
5.2.1 Global Radiopharmaceutical Injector Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Radiopharmaceutical Injector Sales Volume by Region (2020-2025)
5.2.3 Global Radiopharmaceutical Injector Sales Volume by Region (2026-2031)
5.2.4 Global Radiopharmaceutical Injector Sales Volume by Region (%), (2020-2031)
5.3 Global Radiopharmaceutical Injector Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Radiopharmaceutical Injector Sales Value, 2020-2031
5.4.2 North America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Radiopharmaceutical Injector Sales Value, 2020-2031
5.5.2 Europe Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Radiopharmaceutical Injector Sales Value, 2020-2031
5.6.2 Asia Pacific Radiopharmaceutical Injector Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Radiopharmaceutical Injector Sales Value, 2020-2031
5.7.2 South America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Radiopharmaceutical Injector Sales Value, 2020-2031
5.8.2 Middle East & Africa Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Radiopharmaceutical Injector Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Radiopharmaceutical Injector Sales Value
6.2.1 Key Countries/Regions Radiopharmaceutical Injector Sales Value, 2020-2031
6.2.2 Key Countries/Regions Radiopharmaceutical Injector Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Radiopharmaceutical Injector Sales Value, 2020-2031
6.3.2 United States Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Radiopharmaceutical Injector Sales Value, 2020-2031
6.4.2 Europe Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Radiopharmaceutical Injector Sales Value, 2020-2031
6.5.2 China Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.5.3 China Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Radiopharmaceutical Injector Sales Value, 2020-2031
6.6.2 Japan Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Radiopharmaceutical Injector Sales Value, 2020-2031
6.7.2 South Korea Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Radiopharmaceutical Injector Sales Value, 2020-2031
6.8.2 Southeast Asia Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Radiopharmaceutical Injector Sales Value, 2020-2031
6.9.2 India Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.9.3 India Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medrad, Inc.(Bayer)
7.1.1 Medrad, Inc.(Bayer) Company Information
7.1.2 Medrad, Inc.(Bayer) Introduction and Business Overview
7.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product Offerings
7.1.5 Medrad, Inc.(Bayer) Recent Development
7.2 UNIVERSAL GIKEN
7.2.1 UNIVERSAL GIKEN Company Information
7.2.2 UNIVERSAL GIKEN Introduction and Business Overview
7.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Product Offerings
7.2.5 UNIVERSAL GIKEN Recent Development
7.3 Comecer
7.3.1 Comecer Company Information
7.3.2 Comecer Introduction and Business Overview
7.3.3 Comecer Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Comecer Radiopharmaceutical Injector Product Offerings
7.3.5 Comecer Recent Development
7.4 Sumitomo Heavy Industries
7.4.1 Sumitomo Heavy Industries Company Information
7.4.2 Sumitomo Heavy Industries Introduction and Business Overview
7.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Product Offerings
7.4.5 Sumitomo Heavy Industries Recent Development
7.5 Tema Sinergie
7.5.1 Tema Sinergie Company Information
7.5.2 Tema Sinergie Introduction and Business Overview
7.5.3 Tema Sinergie Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Tema Sinergie Radiopharmaceutical Injector Product Offerings
7.5.5 Tema Sinergie Recent Development
7.6 Lemer Pax
7.6.1 Lemer Pax Company Information
7.6.2 Lemer Pax Introduction and Business Overview
7.6.3 Lemer Pax Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Lemer Pax Radiopharmaceutical Injector Product Offerings
7.6.5 Lemer Pax Recent Development
7.7 BQSV
7.7.1 BQSV Company Information
7.7.2 BQSV Introduction and Business Overview
7.7.3 BQSV Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 BQSV Radiopharmaceutical Injector Product Offerings
7.7.5 BQSV Recent Development
8 Industry Chain Analysis
8.1 Radiopharmaceutical Injector Industrial Chain
8.2 Radiopharmaceutical Injector Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Radiopharmaceutical Injector Sales Model
8.5.2 Sales Channel
8.5.3 Radiopharmaceutical Injector Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Radiopharmaceutical Injector Product Introduction
1.2 Global Radiopharmaceutical Injector Market Size Forecast
1.2.1 Global Radiopharmaceutical Injector Sales Value (2020-2031)
1.2.2 Global Radiopharmaceutical Injector Sales Volume (2020-2031)
1.2.3 Global Radiopharmaceutical Injector Sales Price (2020-2031)
1.3 Radiopharmaceutical Injector Market Trends & Drivers
1.3.1 Radiopharmaceutical Injector Industry Trends
1.3.2 Radiopharmaceutical Injector Market Drivers & Opportunity
1.3.3 Radiopharmaceutical Injector Market Challenges
1.3.4 Radiopharmaceutical Injector Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Radiopharmaceutical Injector Players Revenue Ranking (2024)
2.2 Global Radiopharmaceutical Injector Revenue by Company (2020-2025)
2.3 Global Radiopharmaceutical Injector Players Sales Volume Ranking (2024)
2.4 Global Radiopharmaceutical Injector Sales Volume by Company Players (2020-2025)
2.5 Global Radiopharmaceutical Injector Average Price by Company (2020-2025)
2.6 Key Manufacturers Radiopharmaceutical Injector Manufacturing Base and Headquarters
2.7 Key Manufacturers Radiopharmaceutical Injector Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Radiopharmaceutical Injector
2.9 Radiopharmaceutical Injector Market Competitive Analysis
2.9.1 Radiopharmaceutical Injector Market Concentration Rate (2020-2025)
2.9.2 Global 5 and 10 Largest Manufacturers by Radiopharmaceutical Injector Revenue in 2024
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Injector as of 2024)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 PET Radioactive Drugs Injector
3.1.2 PET and SPECT Radioactive Drugs Injector
3.2 Global Radiopharmaceutical Injector Sales Value by Type
3.2.1 Global Radiopharmaceutical Injector Sales Value by Type (2020 VS 2024 VS 2031)
3.2.2 Global Radiopharmaceutical Injector Sales Value, by Type (2020-2031)
3.2.3 Global Radiopharmaceutical Injector Sales Value, by Type (%) (2020-2031)
3.3 Global Radiopharmaceutical Injector Sales Volume by Type
3.3.1 Global Radiopharmaceutical Injector Sales Volume by Type (2020 VS 2024 VS 2031)
3.3.2 Global Radiopharmaceutical Injector Sales Volume, by Type (2020-2031)
3.3.3 Global Radiopharmaceutical Injector Sales Volume, by Type (%) (2020-2031)
3.4 Global Radiopharmaceutical Injector Average Price by Type (2020-2031)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Clinics
4.1.2 R&D Institution
4.2 Global Radiopharmaceutical Injector Sales Value by Application
4.2.1 Global Radiopharmaceutical Injector Sales Value by Application (2020 VS 2024 VS 2031)
4.2.2 Global Radiopharmaceutical Injector Sales Value, by Application (2020-2031)
4.2.3 Global Radiopharmaceutical Injector Sales Value, by Application (%) (2020-2031)
4.3 Global Radiopharmaceutical Injector Sales Volume by Application
4.3.1 Global Radiopharmaceutical Injector Sales Volume by Application (2020 VS 2024 VS 2031)
4.3.2 Global Radiopharmaceutical Injector Sales Volume, by Application (2020-2031)
4.3.3 Global Radiopharmaceutical Injector Sales Volume, by Application (%) (2020-2031)
4.4 Global Radiopharmaceutical Injector Average Price by Application (2020-2031)
5 Segmentation by Region
5.1 Global Radiopharmaceutical Injector Sales Value by Region
5.1.1 Global Radiopharmaceutical Injector Sales Value by Region: 2020 VS 2024 VS 2031
5.1.2 Global Radiopharmaceutical Injector Sales Value by Region (2020-2025)
5.1.3 Global Radiopharmaceutical Injector Sales Value by Region (2026-2031)
5.1.4 Global Radiopharmaceutical Injector Sales Value by Region (%), (2020-2031)
5.2 Global Radiopharmaceutical Injector Sales Volume by Region
5.2.1 Global Radiopharmaceutical Injector Sales Volume by Region: 2020 VS 2024 VS 2031
5.2.2 Global Radiopharmaceutical Injector Sales Volume by Region (2020-2025)
5.2.3 Global Radiopharmaceutical Injector Sales Volume by Region (2026-2031)
5.2.4 Global Radiopharmaceutical Injector Sales Volume by Region (%), (2020-2031)
5.3 Global Radiopharmaceutical Injector Average Price by Region (2020-2031)
5.4 North America
5.4.1 North America Radiopharmaceutical Injector Sales Value, 2020-2031
5.4.2 North America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
5.5 Europe
5.5.1 Europe Radiopharmaceutical Injector Sales Value, 2020-2031
5.5.2 Europe Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
5.6 Asia Pacific
5.6.1 Asia Pacific Radiopharmaceutical Injector Sales Value, 2020-2031
5.6.2 Asia Pacific Radiopharmaceutical Injector Sales Value by Region (%), 2024 VS 2031
5.7 South America
5.7.1 South America Radiopharmaceutical Injector Sales Value, 2020-2031
5.7.2 South America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
5.8 Middle East & Africa
5.8.1 Middle East & Africa Radiopharmaceutical Injector Sales Value, 2020-2031
5.8.2 Middle East & Africa Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Radiopharmaceutical Injector Sales Value Growth Trends, 2020 VS 2024 VS 2031
6.2 Key Countries/Regions Radiopharmaceutical Injector Sales Value
6.2.1 Key Countries/Regions Radiopharmaceutical Injector Sales Value, 2020-2031
6.2.2 Key Countries/Regions Radiopharmaceutical Injector Sales Volume, 2020-2031
6.3 United States
6.3.1 United States Radiopharmaceutical Injector Sales Value, 2020-2031
6.3.2 United States Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.3.3 United States Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.4 Europe
6.4.1 Europe Radiopharmaceutical Injector Sales Value, 2020-2031
6.4.2 Europe Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.4.3 Europe Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.5 China
6.5.1 China Radiopharmaceutical Injector Sales Value, 2020-2031
6.5.2 China Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.5.3 China Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.6 Japan
6.6.1 Japan Radiopharmaceutical Injector Sales Value, 2020-2031
6.6.2 Japan Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.6.3 Japan Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.7 South Korea
6.7.1 South Korea Radiopharmaceutical Injector Sales Value, 2020-2031
6.7.2 South Korea Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.7.3 South Korea Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.8 Southeast Asia
6.8.1 Southeast Asia Radiopharmaceutical Injector Sales Value, 2020-2031
6.8.2 Southeast Asia Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.8.3 Southeast Asia Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
6.9 India
6.9.1 India Radiopharmaceutical Injector Sales Value, 2020-2031
6.9.2 India Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
6.9.3 India Radiopharmaceutical Injector Sales Value by Application, 2024 VS 2031
7 Company Profiles
7.1 Medrad, Inc.(Bayer)
7.1.1 Medrad, Inc.(Bayer) Company Information
7.1.2 Medrad, Inc.(Bayer) Introduction and Business Overview
7.1.3 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product Offerings
7.1.5 Medrad, Inc.(Bayer) Recent Development
7.2 UNIVERSAL GIKEN
7.2.1 UNIVERSAL GIKEN Company Information
7.2.2 UNIVERSAL GIKEN Introduction and Business Overview
7.2.3 UNIVERSAL GIKEN Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 UNIVERSAL GIKEN Radiopharmaceutical Injector Product Offerings
7.2.5 UNIVERSAL GIKEN Recent Development
7.3 Comecer
7.3.1 Comecer Company Information
7.3.2 Comecer Introduction and Business Overview
7.3.3 Comecer Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Comecer Radiopharmaceutical Injector Product Offerings
7.3.5 Comecer Recent Development
7.4 Sumitomo Heavy Industries
7.4.1 Sumitomo Heavy Industries Company Information
7.4.2 Sumitomo Heavy Industries Introduction and Business Overview
7.4.3 Sumitomo Heavy Industries Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Sumitomo Heavy Industries Radiopharmaceutical Injector Product Offerings
7.4.5 Sumitomo Heavy Industries Recent Development
7.5 Tema Sinergie
7.5.1 Tema Sinergie Company Information
7.5.2 Tema Sinergie Introduction and Business Overview
7.5.3 Tema Sinergie Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Tema Sinergie Radiopharmaceutical Injector Product Offerings
7.5.5 Tema Sinergie Recent Development
7.6 Lemer Pax
7.6.1 Lemer Pax Company Information
7.6.2 Lemer Pax Introduction and Business Overview
7.6.3 Lemer Pax Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Lemer Pax Radiopharmaceutical Injector Product Offerings
7.6.5 Lemer Pax Recent Development
7.7 BQSV
7.7.1 BQSV Company Information
7.7.2 BQSV Introduction and Business Overview
7.7.3 BQSV Radiopharmaceutical Injector Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 BQSV Radiopharmaceutical Injector Product Offerings
7.7.5 BQSV Recent Development
8 Industry Chain Analysis
8.1 Radiopharmaceutical Injector Industrial Chain
8.2 Radiopharmaceutical Injector Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Radiopharmaceutical Injector Sales Model
8.5.2 Sales Channel
8.5.3 Radiopharmaceutical Injector Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Radiopharmaceutical Injector Market Trends
Table 2. Radiopharmaceutical Injector Market Drivers & Opportunity
Table 3. Radiopharmaceutical Injector Market Challenges
Table 4. Radiopharmaceutical Injector Market Restraints
Table 5. Global Radiopharmaceutical Injector Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Radiopharmaceutical Injector Revenue Market Share by Company (2020-2025)
Table 7. Global Radiopharmaceutical Injector Sales Volume by Company (2020-2025) & (Units)
Table 8. Global Radiopharmaceutical Injector Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Radiopharmaceutical Injector Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Radiopharmaceutical Injector Manufacturing Base and Headquarters
Table 11. Key Manufacturers Radiopharmaceutical Injector Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Radiopharmaceutical Injector
Table 13. Global Radiopharmaceutical Injector Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Injector as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Radiopharmaceutical Injector Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Radiopharmaceutical Injector Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Radiopharmaceutical Injector Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Radiopharmaceutical Injector Sales Market Share in Value by Type (2020-2025)
Table 20. Global Radiopharmaceutical Injector Sales Market Share in Value by Type (2026-2031)
Table 21. Global Radiopharmaceutical Injector Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
Table 22. Global Radiopharmaceutical Injector Sales Volume by Type (2020-2025) & (Units)
Table 23. Global Radiopharmaceutical Injector Sales Volume by Type (2026-2031) & (Units)
Table 24. Global Radiopharmaceutical Injector Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Radiopharmaceutical Injector Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Radiopharmaceutical Injector Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Radiopharmaceutical Injector Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Radiopharmaceutical Injector Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Radiopharmaceutical Injector Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Radiopharmaceutical Injector Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Radiopharmaceutical Injector Sales Market Share in Value by Application (2020-2025)
Table 32. Global Radiopharmaceutical Injector Sales Market Share in Value by Application (2026-2031)
Table 33. Global Radiopharmaceutical Injector Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
Table 34. Global Radiopharmaceutical Injector Sales Volume by Application (2020-2025) & (Units)
Table 35. Global Radiopharmaceutical Injector Sales Volume by Application (2026-2031) & (Units)
Table 36. Global Radiopharmaceutical Injector Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Radiopharmaceutical Injector Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Radiopharmaceutical Injector Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Radiopharmaceutical Injector Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Radiopharmaceutical Injector Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Radiopharmaceutical Injector Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Radiopharmaceutical Injector Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Radiopharmaceutical Injector Sales Value by Region (2020-2025) & (%)
Table 44. Global Radiopharmaceutical Injector Sales Value by Region (2026-2031) & (%)
Table 45. Global Radiopharmaceutical Injector Sales Volume by Region (Units): 2020 VS 2024 VS 2031
Table 46. Global Radiopharmaceutical Injector Sales Volume by Region (2020-2025) & (Units)
Table 47. Global Radiopharmaceutical Injector Sales Volume by Region (2026-2031) & (Units)
Table 48. Global Radiopharmaceutical Injector Sales Volume by Region (2020-2025) & (%)
Table 49. Global Radiopharmaceutical Injector Sales Volume by Region (2026-2031) & (%)
Table 50. Global Radiopharmaceutical Injector Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Radiopharmaceutical Injector Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Radiopharmaceutical Injector Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Radiopharmaceutical Injector Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Radiopharmaceutical Injector Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Radiopharmaceutical Injector Sales Volume, (2020-2025) & (Units)
Table 56. Key Countries/Regions Radiopharmaceutical Injector Sales Volume, (2026-2031) & (Units)
Table 57. Medrad, Inc.(Bayer) Company Information
Table 58. Medrad, Inc.(Bayer) Introduction and Business Overview
Table 59. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product Offerings
Table 61. Medrad, Inc.(Bayer) Recent Development
Table 62. UNIVERSAL GIKEN Company Information
Table 63. UNIVERSAL GIKEN Introduction and Business Overview
Table 64. UNIVERSAL GIKEN Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. UNIVERSAL GIKEN Radiopharmaceutical Injector Product Offerings
Table 66. UNIVERSAL GIKEN Recent Development
Table 67. Comecer Company Information
Table 68. Comecer Introduction and Business Overview
Table 69. Comecer Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Comecer Radiopharmaceutical Injector Product Offerings
Table 71. Comecer Recent Development
Table 72. Sumitomo Heavy Industries Company Information
Table 73. Sumitomo Heavy Industries Introduction and Business Overview
Table 74. Sumitomo Heavy Industries Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sumitomo Heavy Industries Radiopharmaceutical Injector Product Offerings
Table 76. Sumitomo Heavy Industries Recent Development
Table 77. Tema Sinergie Company Information
Table 78. Tema Sinergie Introduction and Business Overview
Table 79. Tema Sinergie Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Tema Sinergie Radiopharmaceutical Injector Product Offerings
Table 81. Tema Sinergie Recent Development
Table 82. Lemer Pax Company Information
Table 83. Lemer Pax Introduction and Business Overview
Table 84. Lemer Pax Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Lemer Pax Radiopharmaceutical Injector Product Offerings
Table 86. Lemer Pax Recent Development
Table 87. BQSV Company Information
Table 88. BQSV Introduction and Business Overview
Table 89. BQSV Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BQSV Radiopharmaceutical Injector Product Offerings
Table 91. BQSV Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Radiopharmaceutical Injector Downstream Customers
Table 95. Radiopharmaceutical Injector Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Injector Product Picture
Figure 2. Global Radiopharmaceutical Injector Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Radiopharmaceutical Injector Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Radiopharmaceutical Injector Sales Volume (2020-2031) & (Units)
Figure 5. Global Radiopharmaceutical Injector Sales Price (2020-2031) & (US$/Unit)
Figure 6. Radiopharmaceutical Injector Report Years Considered
Figure 7. Global Radiopharmaceutical Injector Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Radiopharmaceutical Injector Players Sales Volume Ranking (2024) & (Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical Injector Revenue in 2024
Figure 10. Radiopharmaceutical Injector Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. PET Radioactive Drugs Injector Picture
Figure 12. PET and SPECT Radioactive Drugs Injector Picture
Figure 13. Global Radiopharmaceutical Injector Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Radiopharmaceutical Injector Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Radiopharmaceutical Injector Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
Figure 16. Global Radiopharmaceutical Injector Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Radiopharmaceutical Injector Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Hospitals and Clinics
Figure 19. Product Picture of R&D Institution
Figure 20. Global Radiopharmaceutical Injector Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Radiopharmaceutical Injector Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Radiopharmaceutical Injector Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
Figure 23. Global Radiopharmaceutical Injector Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Radiopharmaceutical Injector Price by Application (2020-2031) & (US$/Unit)
Figure 25. North America Radiopharmaceutical Injector Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Radiopharmaceutical Injector Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Radiopharmaceutical Injector Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Radiopharmaceutical Injector Sales Volume (%), (2020-2031)
Figure 37. United States Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 43. China Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 45. China Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 55. India Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 57. India Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 58. Radiopharmaceutical Injector Industrial Chain
Figure 59. Radiopharmaceutical Injector Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Table 1. Radiopharmaceutical Injector Market Trends
Table 2. Radiopharmaceutical Injector Market Drivers & Opportunity
Table 3. Radiopharmaceutical Injector Market Challenges
Table 4. Radiopharmaceutical Injector Market Restraints
Table 5. Global Radiopharmaceutical Injector Revenue by Company (2020-2025) & (US$ Million)
Table 6. Global Radiopharmaceutical Injector Revenue Market Share by Company (2020-2025)
Table 7. Global Radiopharmaceutical Injector Sales Volume by Company (2020-2025) & (Units)
Table 8. Global Radiopharmaceutical Injector Sales Volume Market Share by Company (2020-2025)
Table 9. Global Market Radiopharmaceutical Injector Price by Company (2020-2025) & (US$/Unit)
Table 10. Key Manufacturers Radiopharmaceutical Injector Manufacturing Base and Headquarters
Table 11. Key Manufacturers Radiopharmaceutical Injector Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Radiopharmaceutical Injector
Table 13. Global Radiopharmaceutical Injector Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical Injector as of 2024)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Radiopharmaceutical Injector Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
Table 17. Global Radiopharmaceutical Injector Sales Value by Type (2020-2025) & (US$ Million)
Table 18. Global Radiopharmaceutical Injector Sales Value by Type (2026-2031) & (US$ Million)
Table 19. Global Radiopharmaceutical Injector Sales Market Share in Value by Type (2020-2025)
Table 20. Global Radiopharmaceutical Injector Sales Market Share in Value by Type (2026-2031)
Table 21. Global Radiopharmaceutical Injector Sales Volume by Type: 2020 VS 2024 VS 2031 (Units)
Table 22. Global Radiopharmaceutical Injector Sales Volume by Type (2020-2025) & (Units)
Table 23. Global Radiopharmaceutical Injector Sales Volume by Type (2026-2031) & (Units)
Table 24. Global Radiopharmaceutical Injector Sales Market Share in Volume by Type (2020-2025)
Table 25. Global Radiopharmaceutical Injector Sales Market Share in Volume by Type (2026-2031)
Table 26. Global Radiopharmaceutical Injector Price by Type (2020-2025) & (US$/Unit)
Table 27. Global Radiopharmaceutical Injector Price by Type (2026-2031) & (US$/Unit)
Table 28. Global Radiopharmaceutical Injector Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
Table 29. Global Radiopharmaceutical Injector Sales Value by Application (2020-2025) & (US$ Million)
Table 30. Global Radiopharmaceutical Injector Sales Value by Application (2026-2031) & (US$ Million)
Table 31. Global Radiopharmaceutical Injector Sales Market Share in Value by Application (2020-2025)
Table 32. Global Radiopharmaceutical Injector Sales Market Share in Value by Application (2026-2031)
Table 33. Global Radiopharmaceutical Injector Sales Volume by Application: 2020 VS 2024 VS 2031 (Units)
Table 34. Global Radiopharmaceutical Injector Sales Volume by Application (2020-2025) & (Units)
Table 35. Global Radiopharmaceutical Injector Sales Volume by Application (2026-2031) & (Units)
Table 36. Global Radiopharmaceutical Injector Sales Market Share in Volume by Application (2020-2025)
Table 37. Global Radiopharmaceutical Injector Sales Market Share in Volume by Application (2026-2031)
Table 38. Global Radiopharmaceutical Injector Price by Application (2020-2025) & (US$/Unit)
Table 39. Global Radiopharmaceutical Injector Price by Application (2026-2031) & (US$/Unit)
Table 40. Global Radiopharmaceutical Injector Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
Table 41. Global Radiopharmaceutical Injector Sales Value by Region (2020-2025) & (US$ Million)
Table 42. Global Radiopharmaceutical Injector Sales Value by Region (2026-2031) & (US$ Million)
Table 43. Global Radiopharmaceutical Injector Sales Value by Region (2020-2025) & (%)
Table 44. Global Radiopharmaceutical Injector Sales Value by Region (2026-2031) & (%)
Table 45. Global Radiopharmaceutical Injector Sales Volume by Region (Units): 2020 VS 2024 VS 2031
Table 46. Global Radiopharmaceutical Injector Sales Volume by Region (2020-2025) & (Units)
Table 47. Global Radiopharmaceutical Injector Sales Volume by Region (2026-2031) & (Units)
Table 48. Global Radiopharmaceutical Injector Sales Volume by Region (2020-2025) & (%)
Table 49. Global Radiopharmaceutical Injector Sales Volume by Region (2026-2031) & (%)
Table 50. Global Radiopharmaceutical Injector Average Price by Region (2020-2025) & (US$/Unit)
Table 51. Global Radiopharmaceutical Injector Average Price by Region (2026-2031) & (US$/Unit)
Table 52. Key Countries/Regions Radiopharmaceutical Injector Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
Table 53. Key Countries/Regions Radiopharmaceutical Injector Sales Value, (2020-2025) & (US$ Million)
Table 54. Key Countries/Regions Radiopharmaceutical Injector Sales Value, (2026-2031) & (US$ Million)
Table 55. Key Countries/Regions Radiopharmaceutical Injector Sales Volume, (2020-2025) & (Units)
Table 56. Key Countries/Regions Radiopharmaceutical Injector Sales Volume, (2026-2031) & (Units)
Table 57. Medrad, Inc.(Bayer) Company Information
Table 58. Medrad, Inc.(Bayer) Introduction and Business Overview
Table 59. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 60. Medrad, Inc.(Bayer) Radiopharmaceutical Injector Product Offerings
Table 61. Medrad, Inc.(Bayer) Recent Development
Table 62. UNIVERSAL GIKEN Company Information
Table 63. UNIVERSAL GIKEN Introduction and Business Overview
Table 64. UNIVERSAL GIKEN Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 65. UNIVERSAL GIKEN Radiopharmaceutical Injector Product Offerings
Table 66. UNIVERSAL GIKEN Recent Development
Table 67. Comecer Company Information
Table 68. Comecer Introduction and Business Overview
Table 69. Comecer Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 70. Comecer Radiopharmaceutical Injector Product Offerings
Table 71. Comecer Recent Development
Table 72. Sumitomo Heavy Industries Company Information
Table 73. Sumitomo Heavy Industries Introduction and Business Overview
Table 74. Sumitomo Heavy Industries Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 75. Sumitomo Heavy Industries Radiopharmaceutical Injector Product Offerings
Table 76. Sumitomo Heavy Industries Recent Development
Table 77. Tema Sinergie Company Information
Table 78. Tema Sinergie Introduction and Business Overview
Table 79. Tema Sinergie Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 80. Tema Sinergie Radiopharmaceutical Injector Product Offerings
Table 81. Tema Sinergie Recent Development
Table 82. Lemer Pax Company Information
Table 83. Lemer Pax Introduction and Business Overview
Table 84. Lemer Pax Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 85. Lemer Pax Radiopharmaceutical Injector Product Offerings
Table 86. Lemer Pax Recent Development
Table 87. BQSV Company Information
Table 88. BQSV Introduction and Business Overview
Table 89. BQSV Radiopharmaceutical Injector Sales (Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
Table 90. BQSV Radiopharmaceutical Injector Product Offerings
Table 91. BQSV Recent Development
Table 92. Key Raw Materials Lists
Table 93. Raw Materials Key Suppliers Lists
Table 94. Radiopharmaceutical Injector Downstream Customers
Table 95. Radiopharmaceutical Injector Distributors List
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Injector Product Picture
Figure 2. Global Radiopharmaceutical Injector Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Global Radiopharmaceutical Injector Sales Value (2020-2031) & (US$ Million)
Figure 4. Global Radiopharmaceutical Injector Sales Volume (2020-2031) & (Units)
Figure 5. Global Radiopharmaceutical Injector Sales Price (2020-2031) & (US$/Unit)
Figure 6. Radiopharmaceutical Injector Report Years Considered
Figure 7. Global Radiopharmaceutical Injector Players Revenue Ranking (2024) & (US$ Million)
Figure 8. Global Radiopharmaceutical Injector Players Sales Volume Ranking (2024) & (Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Radiopharmaceutical Injector Revenue in 2024
Figure 10. Radiopharmaceutical Injector Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 11. PET Radioactive Drugs Injector Picture
Figure 12. PET and SPECT Radioactive Drugs Injector Picture
Figure 13. Global Radiopharmaceutical Injector Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
Figure 14. Global Radiopharmaceutical Injector Sales Value Market Share by Type, 2024 & 2031
Figure 15. Global Radiopharmaceutical Injector Sales Volume by Type (2020 VS 2024 VS 2031) & (Units)
Figure 16. Global Radiopharmaceutical Injector Sales Volume Market Share by Type, 2024 & 2031
Figure 17. Global Radiopharmaceutical Injector Price by Type (2020-2031) & (US$/Unit)
Figure 18. Product Picture of Hospitals and Clinics
Figure 19. Product Picture of R&D Institution
Figure 20. Global Radiopharmaceutical Injector Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
Figure 21. Global Radiopharmaceutical Injector Sales Value Market Share by Application, 2024 & 2031
Figure 22. Global Radiopharmaceutical Injector Sales Volume by Application (2020 VS 2024 VS 2031) & (Units)
Figure 23. Global Radiopharmaceutical Injector Sales Volume Market Share by Application, 2024 & 2031
Figure 24. Global Radiopharmaceutical Injector Price by Application (2020-2031) & (US$/Unit)
Figure 25. North America Radiopharmaceutical Injector Sales Value (2020-2031) & (US$ Million)
Figure 26. North America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 27. Europe Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 28. Europe Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 29. Asia Pacific Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Radiopharmaceutical Injector Sales Value by Region (%), 2024 VS 2031
Figure 31. South America Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 32. South America Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 33. Middle East & Africa Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 34. Middle East & Africa Radiopharmaceutical Injector Sales Value by Country (%), 2024 VS 2031
Figure 35. Key Countries/Regions Radiopharmaceutical Injector Sales Value (%), (2020-2031)
Figure 36. Key Countries/Regions Radiopharmaceutical Injector Sales Volume (%), (2020-2031)
Figure 37. United States Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 38. United States Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 39. United States Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 40. Europe Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 41. Europe Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 42. Europe Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 43. China Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 44. China Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 45. China Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 46. Japan Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 47. Japan Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 48. Japan Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 49. South Korea Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 50. South Korea Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 51. South Korea Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 52. Southeast Asia Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 53. Southeast Asia Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 54. Southeast Asia Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 55. India Radiopharmaceutical Injector Sales Value, (2020-2031) & (US$ Million)
Figure 56. India Radiopharmaceutical Injector Sales Value by Type (%), 2024 VS 2031
Figure 57. India Radiopharmaceutical Injector Sales Value by Application (%), 2024 VS 2031
Figure 58. Radiopharmaceutical Injector Industrial Chain
Figure 59. Radiopharmaceutical Injector Manufacturing Cost Structure
Figure 60. Channels of Distribution (Direct Sales, and Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Fatigue Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global Blast Impact Analysis Engineering Services Market Research Report 2025
Jul 29, 25
Global On-Line Analytical Processing (OLAP) Business Intelligence Consulting Services Market Research Report 2025
Jul 29, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232